The lack of T cell infiltrates is a major obstacle to effective immunotherapy in cancer. Conversely, the formation of tumor-associated tertiary-lymphoid-like structures (TA-TLLSs), which are the local site of humoral and cellular immune responses against cancers, is associated with good prognosis, and they have recently been detected in immune checkpoint blockade (ICB)-responding patients. However, how these lymphoid aggregates develop remains poorly understood. By employing single-cell transcriptomics, endothelial fate mapping, and functional multiplex immune profiling, we demonstrate that antiangiogenic immune-modulating therapies evoke transdifferentiation of postcapillary venules into inflamed high-endothelial venules (HEVs) via lymphotoxin/lymphotoxin beta receptor (LT/LTβR) signaling. In turn, tumor HEVs boost intratumoral lymphocyte influx and foster permissive lymphocyte niches for PD1- and PD1+TCF1+ CD8 T cell progenitors that differentiate into GrzB+PD1+ CD8 T effector cells. Tumor-HEVs require continuous CD8 and NK cell-derived signals revealing that tumor HEV maintenance is actively sculpted by the adaptive immune system through a feed-forward loop.
Pubmed ID: 36423635 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets goat IgG
View all literature mentionsThis polyclonal targets Rabbit IgG
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Armenian Hamster IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Rat IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets Mouse LYMPHOTOXIN BETA RECEPTOR
View all literature mentionsThis monoclonal targets CTLA-4 (CD152)
View all literature mentionsThis monoclonal targets PD-L1 (B7-H1)
View all literature mentionsThis monoclonal targets VEGFR-2
View all literature mentionsThis monoclonal targets IFNγ
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis isotype control targets KLH
View all literature mentionsThis monoclonal targets CD8α
View all literature mentionsThis monoclonal targets CSF1R (CD115)
View all literature mentionsThis monoclonal targets CD16 / CD32
View all literature mentionsThis monoclonal targets Human Perforin
View all literature mentionsThis polyclonal targets Human/Mouse Desmin Affinity Purified Ab
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets KI67
View all literature mentionsThis monoclonal targets Ki-67 (D3B5)
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets XCR1
View all literature mentionsThis monoclonal targets TCF7
View all literature mentionsThis polyclonal targets Human TIM-3
View all literature mentionsThis recombinant monoclonal targets TIM-3
View all literature mentionsThis monoclonal targets CD366
View all literature mentionsThis monoclonal targets CD25 (IL-2 Receptor α)
View all literature mentionsThis monoclonal targets CD317 (PDCA-1)
View all literature mentionsThis monoclonal targets ROR gamma (t)
View all literature mentionsThis monoclonal targets IFN-γ
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets Ly-6G
View all literature mentionsThis monoclonal targets I-A/I-E
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis polyclonal targets Mouse PD-1
View all literature mentionsThis recombinant monoclonal targets PD-1
View all literature mentionsThis monoclonal targets PD-1
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis polyclonal targets Mouse Granzyme B
View all literature mentionsThis recombinant monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis recombinant monoclonal targets FoxP3
View all literature mentionsThis monoclonal targets CD172a
View all literature mentionsThis monoclonal targets LT-betaR
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD64
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets mouse CD4
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets Human CD8A
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD8 alpha
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis polyclonal targets Von Willebrand Factor
View all literature mentionsThis monoclonal targets CD106 (VCAM-1)
View all literature mentionsThis monoclonal targets CD62P (P-Selectin)
View all literature mentionsThis monoclonal targets CD62E (E-Selectin)
View all literature mentionsThis monoclonal targets Mouse N/A
View all literature mentionsThis monoclonal targets PNAd
View all literature mentionsThis monoclonal targets High Endothelial Venule Marker
View all literature mentionsThis monoclonal targets CD54 (ICAM-1)
View all literature mentionsThis monoclonal targets CD31
View all literature mentionsThis monoclonal targets PECAM-1 (CD31, gpIIa)
View all literature mentionsThis polyclonal targets CD31
View all literature mentionsThis monoclonal targets CD45R
View all literature mentions